ARTICLES BY ED HESS
-
4 Questions From The PDA Annual Meeting4/8/2016
A few weeks back I attended the 2016 PDA Annual Meeting held in San Antonio. In general, the main thrust of the conference focused on the technologies and approaches being applied by biopharma manufacturers as they move their therapies from development through commercialization.
-
Flexibility Drives Single-Use Bioreactor Choice3/9/2016
As biologics manufacturers focus on more niche therapies, single-use bioreactors are projected to see significant worldwide growth.
-
4 Takeaways From Cell & Gene Therapy World2/1/2016
Cell and gene therapies hold great promise for patients. Now, the pressure is on the industry to develop processes and solutions that deliver these products economically.